Medicine combination for treating pericardial effusion and preventing complications

Abstract

The invention discloses a medicine combination for treating pericardial effusion and preventing complications. The medicine combination for treating the pericardial effusion and preventing the complications comprises 4-isoniazid, ofloxacin, apigenin, ilexisaponin, ursolic acid, scopoletin, ergosterin, aesculetin, oleanolic acid, mycose, melitose, oridonin, vitamin B2, vitamin C, fillers, adhesives, disintegrating agents and lubricants. The medicine combination is used for treating the pericardial effusion, inflammation is controlled, metabolism is regulated by the aid of components for stopping pain, regulating qi, dispersing blood stasis, dredging collaterals and resisting viruses and tumors, symptoms of the pericardial effusion can be controlled, and diseases causing the pericardial effusion and the complications caused by the pericardial effusion can be relieved.

Description

technical field [0001] The invention relates to the technical field of cardiovascular medical medicine, in particular to a pharmaceutical composition for treating pericardial effusion and preventing complications. Background technique [0002] Due to its complex and variable pathogenesis, cardiovascular disease has become a common disease that seriously threatens human health. With the continuous development of modern medical technology, more diseases that were previously difficult to detect are gradually showing a significant upward trend in people's lives. The imperceptible concealment often brings more pain to patients. Pericardial effusion is a relatively common clinical manifestation and one of the important signs of pericardial disease. Pericardial effusion can be seen in exudative pericarditis and other non-inflammatory pericardial lesions. It can usually be confirmed by physical examination and X-ray examination. Especially after echocardiography became a routine ex...

AI Technical Summary

Problems solved by technology

[0003] At present, there is no unified conclusion on the treatment plan for this disease. Most patients are given treatment plans based on the doctor's personal experience. It is inevitable that there will be problems such as inaccurate control of the disease. Drug treatment generally uses ordinary anti-inflammatory drugs, and surgery Therapy not only increases the risk, but also cannot avoid the possibility of recurrence and various postoperative complications, and lacks a way to start with the cause of the disease to achieve the most effective treatment goal. The disease is mostly caused by infection or tumor, Complications caused by rheumatism, cardiovascular injury and other diseases, so under the premise of anti-inflammatory treatment, combined with anti-tumor, anti-cancer, and drug coordination treatment to enhance the body's immune ability, in order to achieve good curative effect

Images